Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation

The androgen receptor (AR) signaling is a key contributor to tumorigenesis and the progression of prostate cancer. A subset of patients may develop neuroendocrine (NE) features, resulting in resistance to androgen deprivation therapy and poor prognosis. In this study, we combined immunostaining and...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ruopeng, Chen, Lei, Jiang, Zhou, Yu, Minghao, Zhang, Weiwei, Ma, Zehua, Ji, Yiyi, Shen, Kai, Xin, Zhixiang, Qi, Jun, Xue, Wei, Wang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413533/
https://www.ncbi.nlm.nih.gov/pubmed/36033483
http://dx.doi.org/10.3389/fonc.2022.955166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413533/
https://www.ncbi.nlm.nih.gov/pubmed/36033483
http://dx.doi.org/10.3389/fonc.2022.955166

Ejemplares similares